BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 868521)

  • 1. 5-hydroxydopamine, unspecific centrally acting false neurotransmitter.
    Brus R; Herman ZS; Szkilnik R; Dzikowski A; Opielka L; Bonczek A
    Acta Physiol Pol; 1977; 28(1):13-21. PubMed ID: 868521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural effects of dopamine and 5-hydroxytryptamine in centrally chemosympathectomized rats.
    Herman ZS; Brus R; Szkilnik R
    Pol J Pharmacol Pharm; 1976; 28(5):463-7. PubMed ID: 1012976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central effects of prostaglandins F2alpha and E1.
    Herman ZS; Kmieciak-Kolada K; Wolny HL; Slomińska-Zurek J; Bonczek A
    Pol J Pharmacol Pharm; 1976; 28(5):411-21. PubMed ID: 1012972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and long-term effects of intraventricular 6-hydroxydopamine in rats pretreated with a monoamine oxidase inhibitor.
    Vetulani J; Reichenberg K; Wiszniowska G; Marchaj J
    Pol J Pharmacol Pharm; 1977; 29(6):645-56. PubMed ID: 564059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of 6-hydroxydopamine on the behavioral effects induced by apomorphine or clonidine in rats.
    Herman ZS; Brus R; Drybański A; Szkilnik R; Slomińska-Zurek J
    Psychopharmacology (Berl); 1976 Oct; 50(1):73-80. PubMed ID: 827766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of brain biogenic amines in the central thermoregulatory mechanism of the rat (author's transl)].
    Fukushima N
    Hokkaido Igaku Zasshi; 1975 Jul; 50(4):369-85. PubMed ID: 1240080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of 5-hydroxytryptamine given IVC on rat behaviour.
    Drybański Z
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):83-8. PubMed ID: 1208232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of neuropeptide Y on behavior and noradrenaline level in the brain].
    Borisova EV; Sabo G; Zhuravlev BV; Telegdi G
    Biull Eksp Biol Med; 1989 Aug; 108(8):132-5. PubMed ID: 2804310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The central action of gamma-aminobutyric acid in rats.
    Kmieciak-Kolada K; Herman ZS; Kozok J; Bień E; Szwed A
    Arch Immunol Ther Exp (Warsz); 1977; 25(2):181-91. PubMed ID: 869677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of 6-hydroxydopamine on the behavior of rats with differing resistance to stress exposure].
    Gromova EA; Semenova TP; Gasanov GG; Ismaĭlova KhIu; Fast AE; Nesterova IV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1990; 40(2):301-9. PubMed ID: 2166392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
    Cooper BR; Breese GR
    Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
    [No Abstract]   [Full Text] [Related]  

  • 12. Central action of 6-hydroxytryptamine in rats.
    Jamrozik-Kruk Z; Brus R
    Acta Physiol Pol; 1980; 31(3):253-60. PubMed ID: 6160727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of central effects of noradrenaline and dopamine injected into the lateral brain ventricle in rats.
    Zebrowska-Lupina I; Malec D; Kleinrok Z
    Acta Physiol Pol; 1975; 26(3):261-74. PubMed ID: 1242288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects of L-5-hydroxytryptophan after destruction of ascending serotonergic pathways in the rat: the role of catecholaminergic neurons.
    Yunger LM; Harvey JA
    J Pharmacol Exp Ther; 1976 Feb; 196(2):307-15. PubMed ID: 1255478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats.
    Song C; Horrobin DF; Leonard BE
    Pharmacopsychiatry; 2006 May; 39(3):88-99. PubMed ID: 16721697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive and behavioral effects of leu-enkephalin (LENK) or D-Ala2-met-enkephalinamide (DAMEA) in rats after central chemical sympathectomy or serotoninectomy.
    Brus R; Herman ZS; Szkilnik R; Krzemiński T; Juraszczyk Z; Kurcok A
    Pol J Pharmacol Pharm; 1985; 37(1):23-31. PubMed ID: 3929238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
    Crawley JN; Stivers JA; Hommer DW; Skirboll LR; Paul SM
    J Pharmacol Exp Ther; 1986 Feb; 236(2):320-30. PubMed ID: 3003339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of ATP and AMP injected into the lateral ventricles of the brain on behavior in rats.
    Brus R; Herman ZS; Jamrozik Z
    Arch Immunol Ther Exp (Warsz); 1976; 24(4):543-8. PubMed ID: 999470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of the transplantation of noradrenergic nerve tissue on the brain noradrenaline level and on the behavior of rats with destroyed catecholaminergic systems].
    Bragin AG; Vinogradova EA; Gromova EA; Grishchenko NI; Ivanitskiĭ GR
    Dokl Akad Nauk SSSR; 1984; 276(4):999-1002. PubMed ID: 6432509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.